5-Aminolevulinic Acid Fluorescence in High Grade Glioma Surgery: Surgical Outcome, Intraoperative Findings, and Fluorescence Patterns
Open Access
- 8 April 2014
- journal article
- clinical trial
- Published by Wiley in BioMed Research International
- Vol. 2014, 1-8
Abstract
Background. 5-Aminolevulinic acid (5-ALA) fluorescence is a validated technique for resection of high grade gliomas (HGG); the aim of this study was to evaluate the surgical outcome and the intraoperative findings in a consecutive series of patients.Methods. Clinical and surgical data from patients affected by HGG who underwent surgery guided by 5-ALA fluorescence at our Department between June 2011 and February 2014 were retrospectively evaluated. Surgical outcome was evaluated by assessing the resection rate as gross total resection% and%. We finally stratified data for recurrent surgery, tumor location, tumor size, and tumor grade (IV versus III grade sec. WHO).Results. 94 patients were finally enrolled. Overall% and% was achieved in 93% and 100% of patients. Extent of resectionwas dependent on tumor location, tumor grade, and tumor size. In 43% of patients the boundaries of fluorescent tissue exceeded those of tumoral tissue detected by neuronavigation, more frequently in larger (57%)and recurrent (60%) tumors.Conclusions. 5-ALA fluorescence in HGG surgery enables a GTR in 100% of cases even if selection of patients remains a main bias. Recurrent surgery, and location, size, and tumor grade can predict both the surgical outcome and the intraoperative findings.
Keywords
This publication has 25 references indexed in Scilit:
- Phenotypic and functional characterization of Glioblastoma cancer stem cells identified trough 5-aminolevulinic acid-assisted surgeryJournal of Neuro-Oncology, 2014
- 5-aminolevulinic acid (5-ALA) fluorescence guided surgery of high-grade gliomas in eloquent areas assisted by functional mapping. Our experience and review of the literatureActa Neurochirurgica, 2013
- The Value of Glioma Extent of Resection in the Modern Neurosurgical EraFrontiers in Neurology, 2012
- Pathological characterization of the glioblastoma border as shown during surgery using 5-aminolevulinic acid-induced fluorescenceNeuropathology, 2011
- Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experienceJournal of Neuro-Oncology, 2010
- ASSOCIATION OF SURGICALLY ACQUIRED MOTOR AND LANGUAGE DEFICITS ON OVERALL SURVIVAL AFTER RESECTION OF GLIOBLASTOMA MULTIFORMENeurosurgery, 2009
- EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORMENeurosurgery, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiformeJournal of Neuro-Oncology, 2007
- Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialThe Lancet Oncology, 2006